Dilutional hyponatremia in patients with cirrhosis and ascites.
about
Selective vasopressin type 2 receptor antagonist for patients with cirrhosisAdvances in liver transplantation allocation systemsKidney Failure and Liver Allocation: Current Practices and Potential ImprovementsPrevalence and Prognostic Significance of Hyponatremia in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Data from the Akershus Cardiac Examination (ACE) 2 Study.Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.Impact of pretransplant hyponatremia on outcome following liver transplantation.Mortality after hospitalization with mild, moderate, and severe hyponatremia.Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC studyHyponatremia and mortality among patients on the liver-transplant waiting listModerate hyponatremia is associated with increased risk of mortality: evidence from a meta-analysisHyponatremia is a marker of disease severity in HIV-infected patients: a retrospective cohort study.Vasopressin-receptor antagonists.The therapeutic use of vaptans for the treatment of dilutional hyponatremia.Hyponatraemia: more than just a marker of disease severity?Important predictor of mortality in patients with end-stage liver disease.Criteria for liver transplantation in ACLF and outcome.Cirrhosis and portal hypertension: The importance of risk stratification, the role of hepatic venous pressure gradient measurement.Management of ascites and hepatorenal syndrome.Are the Dysnatremias a Permanent Threat to the Critically Ill Patients?Outcome predictors of cirrhotic patients with spontaneous bacterial empyema.Implication of inflammation-related cytokines in the natural history of liver cirrhosis.Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.Incidence, Severity and Prognosis Associated with Hyponatremia in Dogs and Cats.Adhesion molecules as a prognostic marker of liver cirrhosis.Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure.Factors associated with waiting time on the liver transplant list: an analysis of the United Network for Organ Sharing (UNOS) database.Serum sodium and hydration status predict transplant-free survival independent of MELD score in patients with cirrhosis.The value of MELD and sodium in assessing potential liver transplant recipients in the United Kingdom.Survival prediction among patients with non-cancer-related end-stage liver disease
P2860
Q24234739-3FB9BE88-2AED-44B9-8707-B102ACF68673Q26766076-3E890047-C99C-4E60-B5FF-1AE0F53B63A6Q26824109-37A07AF4-7553-4B48-9422-33BD9932D24CQ31121896-C6D8A180-542F-49D0-AA0F-3C9724B67DFEQ33845513-2658E1AB-B661-4848-A3DC-E153532D40B7Q33989198-7B16DF69-3190-440B-9697-678604281DEEQ34551988-62997E53-6D2D-49AA-921A-42895FF7AB5AQ34789475-F8E08558-5AEB-4634-9AC3-51A73E6D7247Q34820619-72EFD2E7-8509-40EE-A3F9-749EABFBAFBBQ35075197-B6FD071F-269E-4114-9746-C8593A37C69EQ36260064-03EB00F3-226F-4893-ADAD-D4F2B933028CQ37770574-FDCF0731-AF9F-499E-87F7-506362355731Q37911141-1386D1B7-0FA4-44B0-A691-31A798C030FFQ38061001-3B989EBB-91CA-49FC-8B0C-3B3402F0AEB1Q38120248-CCB33C02-7DCF-492A-A0F8-205D4BDF8CB6Q38383402-8B00E855-3799-456E-B8FC-7E4C102A593EQ38417924-1B6A09E6-2695-48B6-844B-390C6FB3B3A5Q40081708-FF37644C-9091-47B2-A798-D03CF9735B33Q41835894-8207E3AE-79F4-4427-8199-34321CCCCAFCQ44899770-0CBCB1EA-9C21-49C8-87ED-5549B385B0BFQ45105179-EB0BB02C-076C-4A55-9374-D4D5A927275BQ45365955-1A7448D5-8A43-4866-9155-ACFE8D9322A0Q45733656-220BC037-33C4-4702-B92C-C4AB05A05460Q46223823-16B1B59A-3292-4BFF-9CA6-4C1812BB86F5Q46374828-128F6B74-5FA2-4DF2-B020-406E955C8D28Q46783641-97012EE2-A275-4869-B5F5-A650FDF85D39Q49188592-4D31F54A-1C39-4945-8CD4-B29614023DA0Q51753856-4E07958F-24FA-432A-984F-F6756A46ADD4Q52854342-12E7951B-3B8A-49B1-BFA1-97493D89DD57Q58707371-142233CB-228C-406F-992C-42EC3082A8A2
P2860
Dilutional hyponatremia in patients with cirrhosis and ascites.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Dilutional hyponatremia in patients with cirrhosis and ascites.
@en
Dilutional hyponatremia in patients with cirrhosis and ascites.
@nl
type
label
Dilutional hyponatremia in patients with cirrhosis and ascites.
@en
Dilutional hyponatremia in patients with cirrhosis and ascites.
@nl
prefLabel
Dilutional hyponatremia in patients with cirrhosis and ascites.
@en
Dilutional hyponatremia in patients with cirrhosis and ascites.
@nl
P2093
P1476
Dilutional hyponatremia in patients with cirrhosis and ascites
@en
P2093
Almudena Porcel
Fernando Díaz
Leopoldo Martín-Herrera
Manuel Macías
Paloma Rendón
P304
P356
10.1001/ARCHINTE.162.3.323
P407
P577
2002-02-01T00:00:00Z